Status:
UNKNOWN
Sedation During Noninvasive Ventilation (NIV)
Lead Sponsor:
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions:
Acute Hypercapnic Respiratory Failure
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
In patients undergoing NIV for acute respiratory, lack of tolerance is one of the main reason of failure. This may result in a poor synchrony between the patient and the machine, leading to gross mis...
Detailed Description
In patients undergoing NIV for acute respiratory, lack of tolerance is one of the main reason of failure. This may result in a poor synchrony between the patient and the machine, leading to gross mis...
Eligibility Criteria
Inclusion
- Ph\<7,35 and PaCO2\>50 mmHg with acute respiratory failure
- Signs of respiratory distress and poor synchrony with the ventilator as assessed on the ventilator screen and by looking patient own rate and ventilator recorded rate
Exclusion
- Patients responding well to NIV and not showing signs of poor synchrony
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2017
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT02264626
Start Date
October 1 2014
End Date
October 1 2017
Last Update
October 11 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
San'Orsola Malpighi Hospital, Bologna ITALY
Bologna, Italy, 40138